Jointechlabs, Inc.

About:

Jointechlabs develops regenerative medicine therapies such as MiniTC® & Mini-Stem System® - devices to process body fat in non-surgical use.

Website: http://www.jointechlabs.com

Twitter/X: jointechlabs

Top Investors: IndieBio, EXPERT DOJO, Newchip Accelerator, SOSV, Stemtech LLC

Description:

Jointechlabs is an emerging world leader in point-of-care regenerative medicine therapies with its headquarters in Brandon, FL (outside Tampa). Current products include MiniTC® (for USA) and Mini-Stem System® (for Ex-USA) - medical devices that allow processing of autologous (your own) body fat for use in non-surgical orthopedic and aesthetic procedures in your doctor’s office, providing safe, time efficient, and superior results. Pipeline products include biologic drugs and 3D Bioprinted products to further expand use in orthopedic, wound healing and plastic and reconstructive surgery . For more information, please visit: https://jointechlabs.com/.

Total Funding Amount:

$2.23M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Brandon, Florida, United States

Founded Date:

2014-01-01

Contact Email:

nathan.katz(AT)jointechlabs.com

Founders:

Felix Pustilnik, Nathan Katz, Nishit Pancholi

Number of Employees:

1-10

Last Funding Date:

2022-10-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai